Get the Stockscreener App
5.71
7.31%
-0.45
After Hours:
5.71
Exagen Inc stock is traded at $5.71, with a volume of 357.58K.
It is down -7.31% in the last 24 hours and up +29.77% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$6.16
Open:
$6.14
24h Volume:
357.58K
Relative Volume:
2.19
Market Cap:
$108.37M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-6.0745
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-5.15%
1M Performance:
+29.77%
6M Performance:
+100.35%
1Y Performance:
+304.96%
1-Day Range:
$5.51
$6.31
1-Week Range:
$5.51
$7.20
52-Week Range:
$1.38
$7.20
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
5.71 | 108.37M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen prices public offering of common stock - MSN
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen announces common stock offering, no amount given - TipRanks
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times
Exagen (XGN) Sees Price Target Increase Following Strong Q1 Performance | XGN Stock News - GuruFocus
Marshall Wace LLP Acquires Shares of 16,048 Exagen Inc. (NASDAQ:XGN) - Defense World
KeyBanc maintains Exagen stock at Sector Weight By Investing.com - Investing.com Nigeria
KeyBanc maintains Exagen stock at Sector Weight - Investing.com
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Wins Amidst ... - Yahoo Finance
Earnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dips - Investing.com Nigeria
Exagen Inc (XGN) Q1 2025 Earnings Call Highlights: Revenue Growt - GuruFocus
Exagen Inc. Reports Record Revenue Amid Strategic Growth - TipRanks
Exagen Inc. Earnings Call Highlights Record Growth - TipRanks
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates a - GuruFocus
Exagen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
EXAGEN INC. SEC 10-Q Report - TradingView
Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates at $15.5M, EPS Matches Expectations at -$0.20 - GuruFocus
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume | XGN Stock News - GuruFocus
XGN Projects Revenue Growth and Positive EBITDA by 2025 | XGN Stock News - GuruFocus
Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume - The Manila Times
Exagen Inc. Reports Record Q1 2025 Revenue - TradingView
Exagen Q1 Earnings: Record $15.5M Revenue as New Lupus Test Launch Sparks Growth Path to Profitability - Stock Titan
Geode Capital Management LLC Grows Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Exagen announces senior secured credit facility - MSN
Exagen (XGN) Secures $75 Million Credit Facility to Enhance Fina - GuruFocus
Exagen secures $75 million credit facility with Perceptive Advisors By Investing.com - Investing.com South Africa
Exagen Secures $75 Million Credit Agreement - TipRanks
Exagen Enters up to $75 Million Credit Facility - marketscreener.com
Exagen secures $75 million credit facility with Perceptive Advisors - Investing.com India
Exagen Inc. Announces Senior Secured Credit Facility with Percep - GuruFocus
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):